Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Forma Therapeutics Holdings, Inc. (FMTX) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Forma Therapeutics Holdings, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1538927.
Total stock buying since 2020: $180,000,000.
Total stock sales since 2020: $272,785.
Total stock option exercises since 2020: $92,920.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2022 | 0 | $0 | 27,898 | $272,785 | 15,000 | $75,750 |
| 2020 | 9,343,508 | $180,000,000 | 449,516 | $0 | 3,400 | $17,170 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2022-04 | 0 | $0 | 0 | $0 | 15,000 | $75,750 |
| 2022-02 | 0 | $0 | 27,898 | $272,785 | 0 | $0 |
| 2020-12 | 0 | $0 | 0 | $0 | 3,400 | $17,170 |
| 2020-06 | 9,343,508 | $180,000,000 | 449,516 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-04-08 | Kelly Patrick F. (SVP, Chief Medical Officer) | Option Ex | 15,000 | 5.05 | 75,750 |
| 2022-02-23 | Kelly Patrick F. (SVP, Chief Medical Officer) | Sale | 5,245 | 9.78 | 51,285 |
| 2022-02-23 | Potts Jeannette (See Remarks) | Sale | 4,672 | 9.78 | 45,682 |
| 2022-02-23 | Lee Frank D. (President and CEO) | Sale | 17,981 | 9.78 | 175,818 |
| 2020-12-30 | Potts Jeannette (See Remarks) | Option Ex | 3,400 | 5.05 | 17,170 |
| 2020-06-23 | Kelly Patrick F. (Chief Medical Officer) | Buy | 42,959 | .00 | 0 |
| 2020-06-23 | Kelly Patrick F. (Chief Medical Officer) | Sale | 64,288 | .00 | 0 |
| 2020-06-23 | Wadlinger Mary E. (See Remarks) | Buy | 115,575 | .00 | 0 |
| 2020-06-23 | Wadlinger Mary E. (See Remarks) | Sale | 144,452 | .00 | 0 |
| 2020-06-23 | Paoletti Paolo (Director) | Buy | 45,553 | .00 | 0 |
| 2020-06-23 | Paoletti Paolo (Director) | Sale | 59,361 | .00 | 0 |
| 2020-06-23 | Wellington Biomedical Innovation Master Investors (cayman) I L.p. (10% Owner) | Buy | 1,000,000 | 20.00 | 20,000,000 |
| 2020-06-23 | Shah Rajeev M. | Buy | 4,000,000 | 20.00 | 80,000,000 |
| 2020-06-23 | Kolchinsky Peter (Director) | Buy | 4,000,000 | 20.00 | 80,000,000 |
| 2020-06-23 | Fanucci Marsha (Director) | Buy | 52,532 | .00 | 0 |
| 2020-06-23 | Fanucci Marsha (Director) | Sale | 67,894 | .00 | 0 |
| 2020-06-23 | Clackson Timothy P (Director) | Buy | 23,590 | .00 | 0 |
| 2020-06-23 | Clackson Timothy P (Director) | Sale | 35,067 | .00 | 0 |
| 2020-06-23 | Wirth Peter (Director) | Buy | 63,299 | .00 | 0 |
| 2020-06-23 | Wirth Peter (Director) | Sale | 78,454 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of FMTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Forma Therapeutics Holdings, Inc. (symbol FMTX, CIK number 1538927) see the Securities and Exchange Commission (SEC) website.